NASDAQ:PRTC PureTech Health (PRTC) Stock Price, News & Analysis $22.51 +0.11 (+0.49%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$22.51▼$22.5150-Day Range$21.63▼$31.3052-Week Range$17.08▼$34.00Volume1,709 shsAverage Volume3,286 shsMarket Capitalization$538.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get PureTech Health alerts: Email Address PureTech Health MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.02% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.04Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($3.73) to ($5.20) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.41 out of 5 starsMedical Sector901st out of 936 stocksPharmaceutical Preparations Industry423rd out of 436 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for PureTech Health.Read more about PureTech Health's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.02% of the outstanding shares of PureTech Health have been sold short.Short Interest Ratio / Days to CoverPureTech Health has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PureTech Health has recently decreased by 13.04%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPureTech Health does not currently pay a dividend.Dividend GrowthPureTech Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRTC. Previous Next 2.8 News and Social Media Coverage News SentimentPureTech Health has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for PureTech Health this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for PRTC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PureTech Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.30% of the stock of PureTech Health is held by insiders.Percentage Held by InstitutionsOnly 0.04% of the stock of PureTech Health is held by institutions.Read more about PureTech Health's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for PureTech Health are expected to decrease in the coming year, from ($3.73) to ($5.20) per share.Price to Book Value per Share RatioPureTech Health has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressThis TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.But I can promise that you’ll see all the details for yourself here. About PureTech Health Stock (NASDAQ:PRTC)PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesJuly 23 at 5:06 PM | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialJune 20, 2024 | businesswire.comPureTech Announces Change of Board RoleJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.June 18, 2024 | businesswire.comPureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamJune 13, 2024 | businesswire.comPureTech Health: Results of Annual General MeetingMay 29, 2024 | businesswire.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 23, 2024 | businesswire.comPureTech to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | businesswire.comPureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.May 20, 2024 | finanznachrichten.dePureTech Health plc: PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareMay 20, 2024 | businesswire.comPureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareApril 27, 2024 | seekingalpha.comPureTech Health plc (PRTC) Q4 2023 Earnings Call TranscriptApril 25, 2024 | finance.yahoo.comPureTech Announces Annual Results for Year Ended December 31, 2023April 18, 2024 | businesswire.comPureTech Health: Notice of ResultsApril 16, 2024 | finance.yahoo.comPureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisApril 11, 2024 | lse.co.ukUS FDA hands fast track to PureTech head and neck cancer treatmentApril 11, 2024 | markets.businessinsider.comPureTech's LYT-200 Receives FDA Fast Track Designation For Treatment Of Head & Neck CancersApril 11, 2024 | businesswire.comPureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:PRTC CUSIPN/A CIK1782999 Webwww.puretechhealth.com Phone617-482-2333Fax617-482-3337Employees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.76 Quick Ratio6.76 Sales & Book Value Annual Sales$3.33 million Price / Sales161.76 Cash FlowN/A Price / Cash FlowN/A Book Value$16.94 per share Price / Book1.33Miscellaneous Outstanding Shares23,930,000Free Float22,664,000Market Cap$538.66 million OptionableNot Optionable Beta1.19 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesDr. Bharatt M. Chowrira J.D. (Age 59)Ph.D., CEO & Executive Director Comp: $2.19MMs. Daphne Zohar (Age 53)Founder, Senior Advisor & Board Observer Comp: $3.99MDr. Robert S. Langer Jr. (Age 75)Ph.D., Co-Founder & Non-Executive Director Comp: $135kDr. Eric Elenko Ph.D. (Age 51)President Dr. David R. Elmaleh Ph.D. (Age 76)Co-Founder & Senior Advisor Mr. Eric Green M.B.A.Chief Operating OfficerMs. Allison Mead TalbotHead of Communications & Investor RelationsMr. Charles Sherwood IIIJ.D., Ph.D., General Counsel & Company SecretaryMr. Spencer BallSenior Vice President of Human ResourcesMs. Aleksandra Filipovic M.D.Ph.D., Head of OncologyMore ExecutivesKey CompetitorsMaravai LifeSciencesNASDAQ:MRVICatalyst PharmaceuticalsNASDAQ:CPRXArvinasNASDAQ:ARVNEdgewise TherapeuticsNASDAQ:EWTXGemini TherapeuticsNASDAQ:GMTXView All CompetitorsInstitutional OwnershipAWM Investment Company Inc.Bought 6,900 shares on 5/16/2024Ownership: 0.026%View All Institutional Transactions PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed this year? PureTech Health's stock was trading at $28.18 at the beginning of 2024. Since then, PRTC shares have decreased by 20.1% and is now trading at $22.51. View the best growth stocks for 2024 here. How do I buy shares of PureTech Health? Shares of PRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRTC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTC Stock Alerts